Lewis H. Bender - Mar 6, 2024 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Stock symbol
INTS
Transactions as of
Mar 6, 2024
Transactions value $
$0
Form type
4
Date filed
3/7/2024, 06:01 PM
Previous filing
Jun 29, 2023
Next filing
May 6, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTS Stock Option (right to buy Common Stock) Award $0 +465K $0.00 465K Mar 6, 2024 Common Stock 465K $5.19 Direct F1
transaction INTS Stock Option (right to buy Common Stock) Award $0 +33.6K $0.00 33.6K Mar 6, 2024 Common Stock 33.6K $5.19 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2024.
F2 This option vested 100% on March 6, 2024.